After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from cancer and type 2 diabetes to asthma.

List of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The medical community is still reeling from the COVID-19 pandemic, while fears for other zoonotic viruses emerge. Additionally, political agendas including strong anti-vaccination messaging and the ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...